Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: aphasia -> code stroke major surgical or invasive procedure: lumbar puncture history of present illness: hpi: ms. is an 85yo woman with a pmhx significant for afib on coumadin, dm2, htn, dilated cardiomyopathy and recently diagnosed pna and e coli uti (on abx) who presented to with "aphasia" concerning for stroke. she had been in her usoh (lives at the ) until one hour prior to presentation when she was last seen well. she was then found to unresponsive there. further details are not known. she was then transferred to for further evaluation. of note, she had been diagnosed with pna (unknown location in lung) as well as an e coli uti and was treated with levaquin for the pna and augmentin for the uti. in addition, her coumadin was held on an inr of 5.09 on (she was also given vitamin k to reverse her inr). in the ambulance, initial vs were: bp: 80/50 rr: 16 t: 97 93% ra fs: 331. upon arrival to the ed a code stroke was called. however, she had left gaze deviation with myoclonic jerking of her lle which progressed to pursing movements of her lips. concerned about seizure, she was loaded with 2mg of im lzp twice (five minute interval) with no resolution of sx. 20mg/kg of pht was ordered and she ceased to clinically seize afterwards, though had persistently decreased responsiveness and left gaze deviation. nchct showed global atrophy, but no acute process. past medical history: - paroxysmal atrial fibrillation on coumadin - hypertension/moderate left ventricular hypertrophy - hyperlipidemia, previously on atorvastatin - nonischemic cardiomyopathy, ef 35%, s/p biventricular/icd pacer. - type 2 diabetes c/b retinopathy, neuropathy, nephropathy - chronic kidney disease: baseline cr 1.9 in - rheumatic fever as a child - s/p hysterectomy - stable 10x15x17cm cystic structure in left pelvis seen two weeks ago for diarrhea and subsequently discharged social history: had previously been living in at foley house but was moved to for rehab 2 weeks pta given general medical deterioration . son recently died in and she has been gradually declining per her daughter since then. daughter is health care proxy. also has four grandchildren, three great grandchildren tobacco: 15-pack-year smoker, quit in . etoh: former heavy alcohol use, quit in family history: unknown/non-contributory physical exam: physical examination on admission: vs: (exact vs unavailable) afebrile, 110s/70s, hr: 100s-110s, 100% ra genl: unresponsive, non-verbal. heent: sclerae anicteric, no conjunctival injection, oropharynx clear cv: irregularly irregular rate and rhythm, otherwise nl s1, s2, no murmurs, rubs, or gallops chest: cta bilaterally, no wheezes, rhonchi, rales abd: nabs, soft, ntnd abdomen ext: +ace bandages over b/l le. skin: petechiae covering torso neurologic examination: mental status: non-verbal, though stated name once during examination. left gaze preference. rarely followed commands initially, now does not follow commands. cranial nerves: pupils equally round and reactive to light, 4 to 2 mm bilaterally. no blink to threat. face appears symmetric, +cough and gag. +corneals b/l. motor: normal bulk but increased tone bilaterally. occasional myoclonus noted on left ue and le. sensation: withdraws to pain in all four extremities. reflexes: 1+ and symmetric throughout. toes mute bilaterally. coordination: unable to assess. gait: deferred ******************** physical examination on discharge: ??????? pertinent results: 04:45pm cerebrospinal fluid (csf) protein-47* glucose-137 04:45pm cerebrospinal fluid (csf) wbc-4 rbc-2* polys-85 lymphs-7 monos-6 eos-1 nuc rbcs-1 03:00pm glucose-141* urea n-67* creat-2.6* sodium-140 potassium-3.5 chloride-104 total co2-22 anion gap-18 03:00pm calcium-7.7* phosphate-6.4* magnesium-2.0 03:00pm wbc-9.7 rbc-3.99* hgb-10.3* hct-31.9* mcv-80* mch-25.7* mchc-32.2 rdw-17.5* 03:00pm plt count-120* 03:00pm pt-16.9* ptt-34.8 inr(pt)-1.6* 11:11am pt-17.1* ptt-53.7* inr(pt)-1.6* 09:22am phenytoin-13.9 03:33am glucose-284* urea n-66* creat-2.6* sodium-139 potassium-3.4 chloride-102 total co2-20* anion gap-20 03:33am albumin-3.0* calcium-7.9* phosphate-6.7* magnesium-1.7 03:33am wbc-10.4 rbc-4.11* hgb-10.6* hct-33.5* mcv-82 mch-25.9* mchc-31.7 rdw-17.1* 03:33am neuts-94.1* lymphs-3.7* monos-2.1 eos-0.1 basos-0 03:33am plt count-158 03:33am urine color-yellow appear-hazy sp -1.011 03:33am urine blood-mod nitrite-neg protein-30 glucose-100 ketone-neg bilirubin-neg urobilngn-neg ph-5.0 leuk-lg 03:33am urine rbc-36* wbc-46* bacteria-few yeast-none epi-1 03:33am urine hyaline-4* 03:33am urine mucous-rare 11:40pm urine hours-random 11:40pm urine hours-random 11:40pm urine gr hold-hold 11:40pm urine bnzodzpn-neg barbitrt-neg opiates-neg cocaine-neg amphetmn-neg mthdone-neg 11:40pm urine color-yellow appear-cloudy sp -1.014 11:40pm urine blood-mod nitrite-neg protein-30 glucose-tr ketone-neg bilirubin-neg urobilngn-neg ph-5.0 leuk-lg 11:40pm urine rbc-4* wbc->182* bacteria-mod yeast-none epi-0 11:40pm urine hyaline-10* 11:40pm urine amorph-rare 11:40pm urine wbcclump-many mucous-rare 09:57pm lactate-3.5* 09:52pm type- po2-31* pco2-43 ph-7.26* total co2-20* base xs--8 09:40pm glucose-288* urea n-69* creat-2.6* sodium-139 potassium-3.3 chloride-102 total co2-22 anion gap-18 09:40pm estgfr-using this 09:40pm calcium-8.3* phosphate-6.9*# magnesium-1.8 09:40pm asa-neg ethanol-neg acetmnphn-neg bnzodzpn-neg barbitrt-neg tricyclic-neg 09:40pm neuts-94.0* lymphs-4.2* monos-1.6* eos-0.1 basos-0 09:40pm neuts-94.0* lymphs-4.2* monos-1.6* eos-0.1 basos-0 09:40pm plt count-144* 09:40pm pt-16.8* ptt-29.8 inr(pt)-1.6* ct head : impression: 1. no acute intracranial process. if there remains a high clinical concern for acute ischemia, mri could be considered for more sensitive examination. 2. moderate prominence of the ventricles, out of proportion to sulci, denoting central atrophy, correlate with any clinical history for nph. 3. opacification of the left sphenoid sinus. 4. soft tissue lesions within the subcutaneous fat posterior to the upper cervical neck, also seen on the study. eeg : impression: this is an abnormal portable eeg because of severe diffuse background slowing and attenuation of faster frequencies. much of the eeg is obscured by diffuse emg artifact. these findings are indicative of severe diffuse cerebral dysfunction which is etiologically non- specific. no electrographic seizures are present. cxr : impression: more dense opacity at the left lung base, silhouetting the hemidiaphragm likely in part due to pleural effusion with underlying consolidation not excluded. pulmonary vascular congestion as on prior and cardiomegaly. cxr : mild-to-moderate pulmonary edema which developed between and has improved, though severe cardiomegaly has not. moderate left pleural effusion is unchanged. there is no pneumothorax. transvenous atriobiventricular pacer defibrillator leads are unchanged in their respective positions since . brief hospital course: 85-year-old woman with atrial fibrillation on chronic anticoagulation, diabetes, hypertension, and dilated cardiomyopathy, recent pneumonia and uti treated with levaquin, who initially presented with aphasia concerning for stroke. upon arrival to the ed a code stroke was called, however upon exam she was noted to have left gaze deviation with myoclonic jerking of her lle which progressed to pursing movements of her lips. due to concern for seizure, she was loaded with 2mg of im lzp twice (five minute interval) with no resolution of sx. she was then loaded with 20mg/kg of pht and she ceased to clinically seize afterwards, though she had persistently decreased responsiveness and left gaze deviation. nchct showed global atrophy, but no acute process. eeg posttreatment showed no evidence of recurrent seizure activity. she was admitted to the icu for close monitoring. icu course: # neuro: she was continued on ltm eeg monitoring. she was initially maintained on phenytoin 100mg tid which was subsequently changed to keppra 250mg . she had no further evidence of clinical seizure activity although remained very lethargic, oriented x 1 only and not consistently following commands. lp was performed to rule out meningitis or encephalitis; preliminary results showed protein 47, glucose 127, wbc 4, rbc 2. gram stain negative, cx preliminarily negative. she was continued on empiric coverage with vanc, ceftriaxone, ampicillin, and acyclovir until cx and hsv pcr came back negative. stroke was also considered as a potential etiology for her seizures, particularly in the setting of a fib with a subtherapeutic inr. initial nchct showed no evidence of focal abnormality. she was maintained on a heparin drip for bridging. inr was initially 1.6 but rose to 4.3 and heparin gtt was stopped. coumadin was held. . code status transition to comfort measures: her family indicated that she should be dnr/dni upon her admission. her daughter expressed a desire to pursue palliative care given her overall deterioration and poor mental status. palliative care was consulted. per discussion with her daughter and pcp it was decided that the patient would want to be made comfort measures only. the patient was transferred to the floor and then discharged back to her home skilled nursing facility. . cv: she was maintained on telemetry monitoring. she was continued on her home medications enalapril, furosemide, and simvastatin. she had several brief episodes of vt overnight . pacemaker was interrogated on and showed a fib with intermittent rvr resulting in short runs of vt. pm was functioning appropriately. . pulm: respiratory status remained stable on ra. cxr showed a lll opacity concerning for possible aspiration pneumonia. . id: she remained afebrile with no leukocytosis. ua was positive for gnr which is being treated with ceftriaxone. cxr showed a lll opacity, atelectasis vs. infiltrate. medications on admission: torsemide 5 mg tab 1 tablet(s) by mouth once a day humulin n 100 unit/ml susp, sub-q inj 20 units s/c twice a day cyanocobalamin (vitamin b-12) 1,000 mcg/ml injection 1000 mcg/ml s/c q month cholecalciferol (vitamin d3) 1,000 unit cap 1 capsule(s) by mouth once a day acetaminophen 500 mg tab 2 tablet(s) by mouth three times a day as needed for pain calcitriol 0.25 mcg cap 1 capsule(s) by mouth every other day enalapril maleate 2.5 mg tab 1 (one) tablet(s) by mouth once a day alendronate 70 mg tab 1 (one) tablet(s) by mouth weekly simvastatin 10 mg tab 1 tablet(s) by mouth at bedtime meclizine 12.5 mg tab 1 tablet(s) by mouth once a day sertraline 50 mg tab 1 tablet(s) by mouth once a day ferrous sulfate 325 mg (65 mg iron) tab 1 tablet(s) by mouth twice a day metoprolol succinate er 25 mg 24 hr tab 1 tablet(s) by mouth once a day discharge medications: 1. diazepam 10 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for seizures. disp:*4 tablet(s)* refills:*0* 2. morphine concentrate 100 mg/5 ml (20 mg/ml) solution sig: 2-10 mg po q2h (every 2 hours) as needed for resp distress, pain for 3 weeks: 2-10 mg every 2 hours as needed for resp distress or pain. . disp:*21 dose* refills:*0* discharge disposition: extended care facility: - discharge diagnosis: 1. status epilepticus discharge condition: mental status: confused - always. activity status: bedbound. level of consciousness: lethargic and minimally arousable. discharge instructions: ms. was admitted in status epilepticus without a clear etiology. an aggressive work-up was discussed with the family and ultimately declined in favor of making the patient comfort measures only. the patient is being discharged back to her skilled nursing facility for hospice care. followup instructions: none procedure: spinal tap incision of lung spinal tap incision of lung central venous catheter placement with guidance diagnoses: other primary cardiomyopathies nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere abnormal coagulation profile hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes chronic kidney disease, unspecified paroxysmal ventricular tachycardia long-term (current) use of insulin grand mal status long-term (current) use of anticoagulants encounter for palliative care do not resuscitate status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy cardiomegaly 

Answer: The patient is high likely exposed to